CYTOCARE 532

CYTOCARE 532 is an implant developed by Laboratories Revitacare, a French pharmaceutical company that specializes in cosmetology and aesthetic medical products. It effectively corrects the aging process of the skin while minimizing the appearance of wrinkles and fine lines. In addition, it helps restore the skin’s elasticity, tonicity and moisture level.

CE-certification: CYTOCARE 532 is fully CE-certified.
Higher hydrating capacity: Thanks to the CT50 complex it contains, this variant has the best hydrating capacity in vivo, outperforming other hyaluronic acid-based dermal fillers.

10 prefilled 5ml syringes
20 traceability labels
1 package insert

CYTOCARE 532 helps densify the skin through the on-surface action of keratinocytes and in-depth action of fibroblasts. Plus, it improves skin vitality while protecting the skin from the harmful effects of oxidizing agents.

Rejuvenating complex CT 50
Hyaluronic acid (32 mg)
Buffered preservation media

Results of treatment with this product typically last for months. Please note that actual results may vary among patients depending on their skin type and age.

Cytocare treatment does not usually cause significant downtime.

If your patient has a streptococcal illness, perform a double test prior to using CYTOCARE 532. It is not advisable to use this product in patients with rheumatic fever.
You must not use on patients who have a medical skin condition (or alteration), or those with known hypersensitivity to one of the ingredients of the formulation. The use of this product is contraindicated in these patients.
Avoid mixing with other products. Be aware that hyaluronic acid (one of the key components of the formulation) is incompatible with benzalkonium chloride or other quaternary ammonium salts.

Slight local inflammation
Edema
Tingling skin
Small hematomas
Skin redness